Remove Ethics Remove Government Remove Leads Remove Patients
article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. What is an effective solution?

article thumbnail

Revolutionizing Rare Disease Research: Unleashing the Power of Patient Advocacy and Artificial Intelligence

PM360

Exploring the role of patient advocacy groups and clinical trials while discussing the challenges faced, and how artificial intelligence and modern methods revolutionize the landscape. As a result, newly diagnosed families frequently rely on patient advocacy groups (PAGs) for up-to-date information.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Role of Certified Pharmaceutical Representatives in the Shifting Sales Landscape

Pharmaceutical Representative Training

Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry. Ethical Conduct: In pharma sales, ethical conduct and behavior is crucial. Ethical conduct helps maintain the company’s integrity and foster trust with HCPs and patients.

Sales 52
article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

While maintaining a vigilant approach to marketing compliance is crucial, the FDA may be strategically choosing to address more immediate public health concerns, leading to fewer marketing violation letters being issued. The post Why Is FDA Issuing Fewer Marketing Violation Letters? appeared first on Pharma Marketing Network.

article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

article thumbnail

Leveraging Influencer Networks in Pharma Marketing: Strategies for Building Trust and Engagement

Pharma Marketing Network

By leveraging influencer networks, pharmaceutical brands can effectively convey their messages, promote their products, and ultimately improve patient outcomes. This unique dynamic allows pharma companies to reach specific niches, such as patients with rare diseases or healthcare providers specializing in particular fields.

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

Its three separate Rules (Security, Privacy, and Breach) impose a variety of security controls, documentation, governance, and notice requirements on custodians of protected health information (PHI). The HTI-1 Final Rule is an AI disclosure and governance rule published by the US Department of Health and Human Services (HHS).